DB18032ApprovedInvestigational
Allogenic bone marrow-derived mesenchymal stem cells: Overview.
- First approval
- United States, 2024
- Also known as
- Allogeneic BM-MSC · Allogeneic bone marrow derived human mesenchymal stem cells · Allogeneic bone marrow-derived mesenchymal stromal cells · Allogeneic bone marrow-derived mesenchymal stromal cells (MSCs) · Allogenic bone-marrow-derived mesenchymal stem cells
- Brand names
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of February 24, 2026
Which companies are running trials of Allogenic bone marrow-derived mesenchymal stem cells, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account